Cian Healthcare (BOM:542678) Accounts Payable: ₹135.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542678 Cian Healthcare Ltd BOM:542678
45 GF Score
Price ₹15.48
GF Value ₹8.27
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cian Healthcare Accounts Payable?

Cian Healthcare BOM:542678 +4.95% 45 Accounts Payable is ₹135.2 Mil as of Mar. 2026. GuruFocus rates BOM:542678 with a GF Score™ of 45/100 and a GF Value™ of ₹8.27 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Cian Healthcare's Accounts Payable for the quarter that ended in Mar. 2026 was ₹135.2 Mil.

Cian Healthcare's quarterly Accounts Payable declined from Mar. 2025 (₹416.8 Mil) to Sep. 2025 (₹362.7 Mil) and declined from Sep. 2025 (₹362.7 Mil) to Mar. 2026 (₹135.2 Mil).

Cian Healthcare's annual Accounts Payable increased from Mar. 2024 (₹312.7 Mil) to Mar. 2025 (₹416.8 Mil) but then declined from Mar. 2025 (₹416.8 Mil) to Mar. 2026 (₹135.2 Mil).

Cian Healthcare Accounts Payable Related Terms

Cian Healthcare Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cian Healthcare's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cian Healthcare Accounts Payable Chart

Cian Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 354.97 270.99 312.71 416.76 135.17

Cian Healthcare Semi-Annual Data
Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.71 393.18 416.76 362.69 135.17
BOM:542678
45GF Score
Cian Healthcare Ltd BOM:542678
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cian Healthcare Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹135.2 Mil mean?
Cian Healthcare (BOM:542678) has a Accounts Payable of ₹135.2 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cian Healthcare and its competitors.
Is Cian Healthcare's Accounts Payable too high?
Cian Healthcare's current Accounts Payable is ₹135.2 Mil. Overall, Cian Healthcare has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cian Healthcare's Accounts Payable compare to ZTS and UTHR?
Cian Healthcare's Accounts Payable of ₹135.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cian Healthcare and its competitors. Cian Healthcare's current Accounts Payable is ₹135.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cian Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cian Healthcare (BOM:542678) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹8.27, compared to a current price of ₹15.48 — trading 87.2% above its estimated fair value. The current Accounts Payable is ₹135.2 Mil. Cian Healthcare's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cian Healthcare (BOM:542678), the current Accounts Payable is ₹135.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cian Healthcare (BOM:542678) Overvalued in 2026?

Based on GuruFocus' analysis, Cian Healthcare stock appears to be overvalued. The current stock price of ₹15.48 is trading 87.2% above its estimated GF Value™ of ₹8.27. GuruFocus considers Cian Healthcare to be Significantly Overvalued.

Key valuation signals for BOM:542678:

  • Accounts Payable: ₹135.2 Mil
  • GF Value™: ₹8.27 vs. price of ₹15.48 (87.2% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cian Healthcare Business Description

Address Mundhwa Kharadi Road, Kirtane Baugh, Office No 301 Konark Icon 3rd Floor, Magarpatta Hadapsar, Mundhwa, Pune, MH, IND, 411036
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
45GF Score

Get the complete analysis for BOM:542678

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.48
Price
₹8.27
GF Value